Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: AIDS Care. 2013 Feb 25;25(6):702–709. doi: 10.1080/09540121.2013.772280

Table 3.

Disclosure of HIV serostatus

Accurate Disclosurea of Serostatus Experimental (Accurate Disclosure/Total Disclosure)(%) Control (Accurate Disclosure/Total Disclosure)(%)
Men
 Baseline 60/70 (86%) 44/61 (72%)
 Post-Intervention 76/92 (83%) 46/58 (80%)
Women
 Baseline 95/119 (80%) 83/119 (70%)
 Post-Intervention 96/118 (81%) 76/117 (65%)
a

”Accurate disclosure” indicates participants whose partner correctly identified their HIV serostatus, and “total disclosure” includes those whose partner provided an inaccurate serostatus.